Canada pharma #pharmaceutical #industry #today

Posted On Dec 1 2017 by

#canada pharma # Ferring Pharmaceuticals, a world leader in research. F erring Pharmaceuticals is a research-driven biopharmaceutical company dedicated to researching, developing and marketing innovative treatments in a number of key therapeutic areas including reproductive health, urology, and gastroenterology. Founded in 1950, Ferring now operates from more than 60 countries and employs more than 5000 people throughout the world, while treatments are available in more than 100 countries. At its seven R D centres, Ferring scientists strive to improve existing therapies and to create inventive new treatments that address unmet medical needs and help people of all ages live better. …


Wiley: Continuous Processing in Pharmaceutical Manufacturing – Ganapathy Subramanian #forest #pharma

Posted On Dec 1 2017 by

#pharmaceutical manufacturing process # Continuous Processing in Pharmaceutical Manufacturing With contributions from biotechnologists and bioengineers, this ready reference describes the state of the art in industrial biopharmaceutical production, with a strong focus on continuous processes. Recent advances in single-use technology as well as application guidelines for all types of biopharmaceutical products, from vaccines to antibodies, and from bacterial to insect to mammalian cells are covered. The efficiency, robustness, and quality control of continuous production processes for biopharmaceuticals are reviewed and compared to traditional batch processes for a range of different production systems. Continuous production of bacteriophages Simulated moving bed, expanded …


Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 #pharma #world

Posted On Dec 1 2017 by

#lupin pharma # Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 Sohini Das | Ahmedabad Jan 19, 2016 10:01 AM IST Looking to add $1 billion in revenues from inorganic growth to reach its target turnover of $5 billion by 2018, pharma giant Lupin, which is currently worth $2 billion, says it is open to late stage speciality assets. Lupin s chief financial officer Ramesh Swaminathan told Business Standard that while $200-300 million per acquisition is a sweet spot for the company historically, it does not mean that the company won t look at bigger acquisitions. …


Pharmaceutical Marketing Jobs #api #pharma

Posted On Dec 1 2017 by

#marketing pharmaceuticals # Pharmaceutical Marketing Jobs Formulate decisions that help shape the market, the products and the company. Central to attaining success within a Pharmaceutical Marketing career is the love of fresh ideas. Couple that with a knack for communicating to a range of audiences, and success is yours for the taking. As part of the AstraZeneca Marketing team, you’ll manage communications and build relationships with everyone from medical practitioners and internal sales force teams, to the media and the general public. AstraZeneca’s highly focused training programmes are designed to help you achieve your full potential in Pharmaceutical Marketing. They …


Buy and Sell Used Pharmaceutical Equipment from A & J Machine Inc #juventus #pharma

Posted On Dec 1 2017 by

#used pharma equipment # A & J Machine Inc. A & J Machine was established in 1989 and maintains a 40,000 sq. ft. showroom and state-of-the-art machine shop at it’s coporate headquarters in Farmingdale New York. We buy and sell new and pre-owed pharmaceutical and packaging equipment worldwide as well as providing servicing, installation and consultation. Our staff includes experienced pharmaceutical production experts as well as certified TQM co.nsu.ltansts. We offer total pharmaceutical production solutions to help increase your productivity and eliminate down time More. Featured Products A & J Machine 1640 New Highway Farmingdale, NY 11735 Tel: 631-845-7586 Fax: …


Business – Industry News Channel #jobs #in #pharmaceutical #companies

Posted On Dec 1 2017 by

#latest pharmaceutical news # Business Industry News Channel Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE® immuno-oncology drug for multiple myeloma Amgen (NASDAQ:AMGN) and Boehringer Ingelheim today announced that Amgen has acquired global development and commercial rights from Boehringer Ingelheim for BI 836908 (AMG 420), a bispecific T cell engager (BiTE®) that targets B-cell maturation antigen (BCMA), a potential target for multiple myeloma. Last Updated: Friday, 02 September 2016 Saniona and Boehringer Ingelheim sign collaboration agreement in schizophrenia Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, and Saniona, a leading biotech company in …


CGmp Contract Manufacturing – AbbVie Contract Manufacturing #pharma

Posted On Dec 1 2017 by

#contract manufacturing # CPhl October 4-6, 2016 Barcelona, Spain Booth #3K50 SERVICES CONTRACT MANUFACTURING WITH ABBVIE By choosing AbbVie Contract Manufacturing, your team gets so much more than the typical CMO engagement. Alongside our elite cGMP contract manufacturing facilities, AbbVie’s partners gain integrated access to scientific expertise and processes that have successfully guided many small molecule and biologic medicines through commercialization. As your compound enters our world-class cGMP contact manufacturing facilities, you can rest easy knowing we have done this before. NEWSROOM Putting the “Process” into Process Characterization By Daniel Sayut, Senior Scientist I, Lisa Rives, Senior Scientist II, and …